A23-2 Implantable device datalogs can permit safe withdrawal of long-term warfarin therapy in refractory atrial fibrillation: Results of a long term prospective study

N. Madan; I. El-Gabry; H. B. Rao; S. Saksena

doi:10.1016/eupace/4.Supplement_2.B34-b

$A23-2 Implantable device datalogs can permit safe withdrawal of long-term warfarin therapy in refractory atrial fibrillation: Results of a long term prospective study$

Journal article

Open access

Peer reviewed

A23-2 Implantable device datalogs can permit safe withdrawal of long-term warfarin therapy in refractory atrial fibrillation: Results of a long term prospective study

N. Madan, I. El-Gabry, H. B. Rao and S. Saksena

Europace (London, England), v 4(Supplement_2), pp B34-B34

01 Dec 2003

DOI: https://doi.org/10.1016/eupace/4.Supplement_2.B34-b

Files and links (1)

url

https://doi.org/10.1016/eupace/4.Supplement_2.B34-bView

Published, Version of Record (VoR) Open

Metrics

3 Record Views

Details

Title: A23-2 Implantable device datalogs can permit safe withdrawal of long-term warfarin therapy in refractory atrial fibrillation: Results of a long term prospective study
Creators: N. Madan
I. El-Gabry
H. B. Rao
S. Saksena
Publication Details: Europace (London, England), v 4(Supplement_2), pp B34-B34
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Pediatrics
Other Identifier: 991021838708604721

A23-2 Implantable device datalogs can permit safe withdrawal of long-term warfarin therapy in refractory atrial fibrillation: Results of a long term prospective study

Files and links (1)

Metrics

Details

Drexel University Social media